
Kimberly Ballard
Examiner (ID: 4611, Phone: (571)272-2150 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1675 |
| Total Applications | 843 |
| Issued Applications | 398 |
| Pending Applications | 80 |
| Abandoned Applications | 383 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14501299
[patent_doc_number] => 20190194304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => FACTOR H POTENTIATING ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/173787
[patent_app_country] => US
[patent_app_date] => 2018-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16173787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/173787 | FACTOR H POTENTIATING ANTIBODIES AND USES THEREOF | Oct 28, 2018 | Abandoned |
Array
(
[id] => 14185319
[patent_doc_number] => 20190112364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => ANTI-TAU ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/161586
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16161586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/161586 | Anti-tau antibodies and uses thereof | Oct 15, 2018 | Issued |
Array
(
[id] => 16238253
[patent_doc_number] => 20200255487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => A Cell-Based Seeding Assay for Huntingtin Aggregation
[patent_app_type] => utility
[patent_app_number] => 16/755198
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755198 | A Cell-Based Seeding Assay for Huntingtin Aggregation | Oct 11, 2018 | Pending |
Array
(
[id] => 14213961
[patent_doc_number] => 20190119365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/142666
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16142666
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/142666 | HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE | Sep 25, 2018 | Abandoned |
Array
(
[id] => 15395875
[patent_doc_number] => 10538582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
[patent_app_type] => utility
[patent_app_number] => 16/141914
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 18146
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16141914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/141914 | Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof | Sep 24, 2018 | Issued |
Array
(
[id] => 16283771
[patent_doc_number] => 20200277373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/646536
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -198
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646536
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646536 | ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF | Sep 13, 2018 | Abandoned |
Array
(
[id] => 16283771
[patent_doc_number] => 20200277373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/646536
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -198
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646536
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646536 | ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF | Sep 13, 2018 | Abandoned |
Array
(
[id] => 14534629
[patent_doc_number] => 20190202936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => LOW AFFINITY BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/131591
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16131591
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/131591 | Low affinity blood brain barrier receptor antibodies and uses thereof | Sep 13, 2018 | Issued |
Array
(
[id] => 16673133
[patent_doc_number] => 20210061896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => POLYPEPTIDE AND ANTIBODY BOUND TO POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/643411
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643411 | Polypeptide and antibody bound to polypeptide | Aug 27, 2018 | Issued |
Array
(
[id] => 16468215
[patent_doc_number] => 20200369752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => Monoclonal Antibodies Against Pathological Alpha-Synuclein, and Methods Using Same
[patent_app_type] => utility
[patent_app_number] => 16/640177
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640177 | Monoclonal antibodies against pathological alpha-synuclein, and methods using same | Aug 21, 2018 | Issued |
Array
(
[id] => 17223088
[patent_doc_number] => 11175584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Methods for detecting traumatic brain injury
[patent_app_type] => utility
[patent_app_number] => 16/106699
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 48
[patent_no_of_words] => 27024
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106699
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/106699 | Methods for detecting traumatic brain injury | Aug 20, 2018 | Issued |
Array
(
[id] => 16239646
[patent_doc_number] => 20200256880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => Neuronal Assay Method Involving Calcineurin
[patent_app_type] => utility
[patent_app_number] => 16/639251
[patent_app_country] => US
[patent_app_date] => 2018-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639251 | Neuronal Assay Method Involving Calcineurin | Aug 15, 2018 | Abandoned |
Array
(
[id] => 16848165
[patent_doc_number] => 20210148910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF ATOPIC DERMATITIS AND TREATMENT SELECTION
[patent_app_type] => utility
[patent_app_number] => 16/637294
[patent_app_country] => US
[patent_app_date] => 2018-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637294
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/637294 | COMPOSITIONS AND METHODS FOR TREATMENT OF ATOPIC DERMATITIS AND TREATMENT SELECTION | Aug 14, 2018 | Abandoned |
Array
(
[id] => 13867573
[patent_doc_number] => 20190030127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => AMYLOID CONJUGATE AND USES AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/103810
[patent_app_country] => US
[patent_app_date] => 2018-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16103810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/103810 | AMYLOID CONJUGATE AND USES AND METHODS THEREOF | Aug 13, 2018 | Abandoned |
Array
(
[id] => 16156661
[patent_doc_number] => 20200216563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => HDAC6 AND PROTEIN AGGREGATION
[patent_app_type] => utility
[patent_app_number] => 16/637569
[patent_app_country] => US
[patent_app_date] => 2018-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637569
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/637569 | HDAC6 AND PROTEIN AGGREGATION | Aug 7, 2018 | Abandoned |
Array
(
[id] => 16549753
[patent_doc_number] => 10882902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/058630
[patent_app_country] => US
[patent_app_date] => 2018-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 12
[patent_no_of_words] => 44536
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16058630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/058630 | Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof | Aug 7, 2018 | Issued |
Array
(
[id] => 16028237
[patent_doc_number] => 10676525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Anti-TREM2 antibodies and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/054680
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 24
[patent_no_of_words] => 138776
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054680
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054680 | Anti-TREM2 antibodies and methods of use thereof | Aug 2, 2018 | Issued |
Array
(
[id] => 16169512
[patent_doc_number] => 10711062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Anti-CD33 antibodies and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/054840
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 90972
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054840 | Anti-CD33 antibodies and methods of use thereof | Aug 2, 2018 | Issued |
Array
(
[id] => 14021151
[patent_doc_number] => 20190072569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => BIOMARKERS OF AUTISM SPECTRUM DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/047237
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16047237
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/047237 | Biomarkers of autism spectrum disorder | Jul 26, 2018 | Issued |
| 16/046830 | Methods for Treating Cholesterol-Related Diseases Using Administered Solutions Having Increased Pre-Beta HDL Particles | Jul 25, 2018 | Abandoned |